Sponsor:
Johns Hopkins University
Code:
NCT06128928
Conditions
COVID-19
Vaccine
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
REDES
Control
Brief summary:
Conditions
COVID-19
Vaccine
Study ID
NCT06128928
Start date
Jul 8, 2023
Status verified date
Nov, 2025
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
900 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: REDES: Motivational interviewing training
active comparator: Control: COVID-19 vaccine information
Interventions
REDES
Control
Primary outcome measure
Central contacts
Locations
Johns Hopkins University
Recruiting
Baltimore, Maryland, United States, 21287
Contacts
Principal Investigator:
Kathleen Page, MD
Sponsor
Johns Hopkins University
Last update posted
Nov 12, 2025
Last verified
Nov, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Johns Hopkins University on 2025-11-12.